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Abstract: The leaves of Polygonum minus were fractionated using an eluting solvent to 
evaluate the pharmacological mechanisms underlying the anti-ulcerogenic activity of  
P. minus. Different P. minus fractions were obtained and evaluated for their ulcer 
preventing capabilities using the ethanol induction method. In this study, Sprague Dawley 
rats weighing 150–200 g were used. Different parameters were estimated to identify the 
active fraction underlying the mechanism of the gastroprotective action of P. minus:  
the gastric mucus barrier, as well as superoxide dismutase, total hexosamine, and 
prostaglandin synthesis. Amongst the five fractions from the ethanolic extract of P. minus, 
the ethyl acetate:methanol 1:1 v/v fraction (F2) significantly (p < 0.005) exhibited better 
inhibition of ulcer lesions in a dose-dependent manner. In addition, rats pre-treated with F2 
showed a significant elevation in superoxide dismutase (SOD), hexosamine and PGE2 
levels in the stomach wall mucosa in a dose-dependent matter. Based on these results, the 
ethyl acetate:methanol 1:1 v/v fraction was considered to be the best fraction for mucous 
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protection in the ethanol induction model. The mechanisms underlying this protection were 
attributed to the synthesis of antioxidants and PGE2. 
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1. Introduction 
Peptic ulcer is a common digestive disease and is considered to be a major cause of morbidity and 
mortality [1]. Scientists have postulated that gastric ulcers are caused by an imbalance between 
defense mechanisms such as blood flow rate, mucous/bicarbonate production, and endogenous 
prostaglandin enzymes, and aggressive factors such as stress, hydrochloric acid, Helicobacter pylori, 
smoking, anti-inflammatory drugs, and pepsin production [2–4]. Most research has concentrated on 
natural antioxidants in plant extracts to cure a variety of ailments, including peptic ulcers. Polygonum minus 
is a plant belonging to the family Polygonaceae and is locally called kesum in Malay [5]. This plant 
has a nice, sweet aroma and is commonly used by the Malaysian population as a flavoring ingredient. 
In the last decade, several studies have been reported that P. minus possesses high free radical 
scavenging activity and reducing power using different extracting solvents [6,7]. Researchers have 
concentrated on P. minus in order to identify its phytochemical constituents because it is highly 
aromatic and rich in essential oils [8]. In addition, as it is not toxic in vitro [7] or in vivo [9], it can  
be safely used in humans. Traditionally, P. minus has been used to treat digestive disorders. 
Pharmacologically, P. minus has been reported to possess antimicrobial [10], antiviral, and anticancer 
activity [11]. 
In the current study, the ethanol induction model was used as it has been reported as a rapid and 
convenient model of gastric ulcer induction in experimental animals. As well, ethanol is considered to 
be a necrotizing factor that contributes to the formation of lesions in the gastric mucosa [12]. The 
mechanism underlying this lesion has been demonstrated to involve damage to the vascular 
endothelium causing edema formation and lifting, or it may be due to the stagnation of gastric blood 
flow, resulting in the appearance of hemorrhage, necrosis, and tissue injury [13]. Currently, there are 
no data available regarding the gastroprotective capacity and the mechanism of action of the fractions 
obtained from P. minus. Following the traditional use of P. minus to treat digestive disorders, this 
study was conducted to evaluate for the first time the pharmacological mechanisms underlying the 
anti-ulcerogenic activities of the fractions obtained from an ethanolic extract of P. minus using 
different analytical grade solvents. 
2. Results and Discussions 
2.1. Effect of Polygonum minus Fractions on Gastric Lesions in the Ethanol Induction Model 
All the fractions from the ethanolic extract of P. minus reduced ulcer area significantly (p < 0.05) 
when compared with the CMC (carboxymethyl cellulose) negative control group presented in Figure 1. 
It is clear that F4 had a lower inhibition percentage of ulcer areas (54.34% ± 11.56) when compared 
with the omeprazole positive control group, whereas F2 was the most effective fraction as it inhibition 
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ulcer formation to 90.30% ± 7.49 at the 100 mg/kg pre-treated dose. The gross evaluation shown in 
Figure 2 showed that rats in the CMC negative control group exhibited extreme injury to the mucosa 
from ethanol induction (Figure 2A), while pre-treatment with F1, F3, F4, and F5 showed moderate 
lesions in different ratios (Figure 2C,E–G, respectively). Rats in the OMP pre-treatment positive 
control group and the F2 group showed a reduction in ulcer area compared to other groups (Figure 
2B,D respectively). This result was confirmed after histological examination as shown in Figure 3. In 
the CMC negative control group, the gastric mucosa was extensively damaged with edema and 
leukocyte infiltration of the submucosal layer (Figure 3A). The rats pre-treated with F1, F3, F4, and F5 
showed markedly better reductions in gastric lesion (Figure 3C,E–G, respectively), while the OMP 
positive control group and the F2 group demonstrated significantly better mucosal protection with less 
mucosal damage, edema, and leukocyte infiltration (Figure 3B,D respectively). 
Figure 1. Percentage inhibition of the ulcer area in rats pre-treated with omeprazole  
20 mg/kg and Polygonum minus fractions (F1, F2, F3, F4, and F5; 50 and 100 mg/kg). Each 
column expresses the mean ± SEM of n = 6 using one-way ANOVA. * p < 0.05 vs. omeprazole. 
 
Figure 2. (A) Macroscopic evaluation of the gastric mucosa of rats pre-treated with CMC 
(carboxymethyl cellulose, ulcer control group); (B) Omeprazole, 20 mg/kg (positive control 
group); (C) F1 100 mg/kg; (D) F2 100 mg/kg; (E) F3 100 mg/kg; (F) F4 100 mg/kg; (G) F5 
100 mg/kg (magnification: 1.8×). The black arrows indicate gastric lesions. 
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Figure 3. (A) Histological evaluation of the gastric mucosa of rats pre-treated with CMC 
(ulcer control group); (B) Omeprazole, 20 mg/kg (positive control group); (C) F1 100 mg/kg; 
(D) F2 100 mg/kg; (E) F3 100 mg/kg; (F) F4 100 mg/kg; (G) F5 100 mg/kg. White arrows 
represent severe disruptions to the surface epithelium and deep mucosa, while black arrows 
represent leukocyte infiltration and edema in the submucosal layer (H & E stain; 10×). 
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The present study focused on fractions of P. minus, using different analytical HPLC grade solvents, 
to evaluate the mechanism of gastroprotection mediated by this plant. Peptic ulcer is postulated to be a 
multifactor disease, but each factor acts via a particular mechanism to contribute to the aetiology of the 
mucus lesion [14]. The mechanism of ethanol induction is attributed to the creation of free radicals and 
an elevation in lipid peroxidation [15], which are considered major agents of inflammation and tissue 
injuries [16]. In contrast, most plant resources possess markedly high antioxidant and total phenolic 
compounds that play an important role in the scavenging of free radicals [17,18]. 
The current medical treatment of peptic ulcer is in general based on the enhancing of mucosal 
defense against necrotizing effects such as alcohol as well as none steroidal anti-inflammatory drugs 
(NSAIDs). However, one of the major problems in gastro-duodenal ulcer treatment is that despite the 
healing rate of 80–100% after 4–8 weeks of therapy with H2 antagonists and proton pump inhibitors, 
the rate of ulcer recurrence within 1 year after stopping management is between 40% and 80% [19]. 
Besides, most of these drugs lack effect on other factors involved in ulcer disease and therefore, do not 
achieve all treatment goals. In addition, it can result in several adverse reactions and expensive. Hence, 
there is a strong need for more effective and safe anti-ulcer agents [20]. 
Several beneficial plant extract are used to enhance the mucosal defense mechanism, shift in proton 
pump, stabilizing surface epithelial cells or interfering with prostaglandin synthesis [21]. Moreover, 
plant extracts are the important sources for the new drug development due to their greater safety and 
high antioxidant composition. 
In the present study, the results of the gross and histological evaluations showed that  
ethyl acetate:methanol 1:1 v/v fraction F2 from P. minus promoted better inhibition of lesions in the 
gastric mucosa compared to the other fractions (Figures 1, 2D and 3D). The high content of phenolic 
compounds, namely gallic acid and coumaric acid, could be the main active compounds of this plant, 
particularly in F2, which displayed potentially significant ulcer prevention effects upon the stomach 
and is worthy of further consideration [22,23]. 
As the incidence of gastric ulcer increases over time, scientists expect it to have a significant effect 
on the health, patients lives and the economic system of related countries [24] in addition, non 
steroidal anti-inflammatory drugs NSAIDs have now become a regular prescriptive drug in the family, 
which is a powerful cause of gastric ulcer. Hence, a widespread search has been necessary to identify 
new anti-ulcer therapies from natural resources. Several clinical researches have confirmed the 
gastroprotection activities conferred by plants on patients [25–27]. This study is further providing 
insights into the future use of herb based drugs as alternative prevention and treatments for gastric 
ulcer. Accordingly, the phenolic compounds from P. minus could be potentially used as a natural drug 
to protect human mucosa from necrotizing agents. 
2.2. Effect of Polygonum minus Fractions on the Mucus Wall Barrier 
Gastric mucus wall production after pre-treatment with all the fractions was increased in a  
dose-dependent matter, as shown in Figure 4. The animals which were treated with 100 mg/kg F2 and 
F5 showed increased production of mucus (115.29 mg/g ± 3.69 and 113.8 mg/g ± 6.85, respectively); 
there was no significant difference (p < 0.05) between these groups and the omeprazole positive 
control group. 
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Figure 4. Effect of the fractions obtained from Polygonum minus on the mucus content in 
gastric tissue. Data are expressed as mean ± SEM (n = 6) * significantly different in 
comparison to omeprazole, p < 0.05 using one-way ANOVA. 
 
2.3. Effect of Polygonum minus Fractions on PGE2 Synthesis 
The PGE2 synthesis level increased significantly (p < 0.05) in all groups compared to the CMC 
negative control group. The F2 pre-treated group exhibited no significant difference with the PGE2 
synthesis (123.9 pg/mL ± 5.52) in comparison with the omeprazole positive control group  
(152.2 pg/mL ± 32.45; Figure 5). 
Figure 5. Effect of the fractions obtained from Polygonum minus on the PGE2 synthesis 
level in gastric tissue. Data are expressed as mean ± SEM (n = 6) * significantly different 
in comparison to omeprazole, p < 0.05 using one-way ANOVA. 
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2.4. Effect of the Polygonum minus Fractions on the Hexosamine Level 
All the fractions markedly showed high levels of hexosamin, and they are significantly (p < 0.05) 
different compare to CMC negative control group. The rats pretreated with F2 (82.95 μg/g ± 3.45) 
showed highest level of hexosamin and there is no significant difference (p < 0.05) with omeprazol 
positive control group (81.60 μg/g ± 5.41) (Figure 6). 
Figure 6. Effect of the fractions obtained from Polygonum minus on the hexosamine 
content in gastric tissue. Data expressed as mean ± SEM (n = 6). * significantly different in 
comparison to omeprazole, p < 0.05 using one-way ANOVA. 
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The ulcer prevention activity of phenolic compounds and their derivatives, notably demonstrated in 
various gastric induction models, have been postulated to occur by mechanisms that include the 
stimulation of prostaglandin synthesis, the elevation of mucus production and the reduction of gastric 
pH [28]. Accordingly, the PGE2 synthesis level was determined in gastric tissue homogenates; 
sustained PGE2 levels were observed in the case of treatment with omeprazole, a reference drug used 
as an antiulcer intervention. Furthermore, the mucus barrier is an important agent in ulcer  
protection [29]. In the present research, (Figure 4) shows that F2 promoted better mucus production 
compared to the other fractions. PGE2 is a main stimulant of mucus production in the stomach, and 
this finding is in agreement with a previous report [30]. Besides PGE2 and its relation to mucus 
production, hexosamine, which is the main glycoprotein of mucous tissue in the stomach, was 
positively correlated with mucus production. Figure 6 demonstrates that F2, which was associated with 
high mucus production, promoted high levels of hexosamine. These results agree with a previous study 
reported by Bhattacharya, et al.[31]. 
2.5. Effect of Polygonum minus Fractions on Superoxide Dismutase (SOD) Activity 
Enzyme scavenging activity, particularly via SOD, as presented in Figure 7, showed that F2  
(5.68 ± 0.1 unit/mg) and F5 (4.27 ± 0.06 unit/mg) significantly (p < 0.05) promoted scavenging 
activity against ethanol-induced ulcers. In contrast, F1 at 50 mg/kg, as well as F3 and F4 at both treated 
doses showed significantly different results (p < 0.05) compared to the omeprazole treated group. 
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Figure 7. Effect of the fractions obtained from Polygonum minus on the activity of 
superoxide dismutase (SOD) in the gastric mucosa. Data are expressed as mean ± SEM (n = 6). 
* significantly different in comparison to omeprazole, p < 0.05 using one-way ANOVA. 
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In addition, we assessed the antioxidant enzyme level as a gastroprotection mechanism. As 
mentioned previously, oxidative stress is one of the main causes of gastric ulcers induced by ethanol. 
Hence, antioxidants are hypothesized to be one of the prevention factors against ethanol-induced ulcers. 
Previous work showed the powerful in vitro antioxidant activity of P. minus [7,32]. Therefore, this 
study examined the activity of an in vivo enzymatic scavenger such as SOD. This enzyme is 
considered as the first line of defence against reactive oxygen species [22]. The results show that  
pre-treatment with F2 promoted ulcer prevention and was associated with higher levels of SOD 
compared to omeprazole. On the other hand, pre-treatment with F3 and F4, with a low ulcer inhibition 
percentage, showed a reduction in the SOD level which may have been partly responsible for oxidative 
damage to the stomach tissue. 
2.6. Phytochemical Analysis 
The phytochemical analysis were performed using HPLC and UPLC-ESI-MS/MS, High 
performance liquid chromatography analysis determined the phenolic compounds contained in the 
ethanolic extract of P. minus fraction (F2). It was shown that F2 was the fraction with highest amount 
of phenolic compounds such as gallic acid, rutin, coumaric acid and quercetin as presented in Figure 8B. 
After comparing the peaks to those of the standard (Figure 8A), gallic acid was found to be the main 
active compound, followed by coumaric acid. The results were confirmed by UPLC-ESI-MS/MS, and 
these data were matched with the theoretical results available in our lab. 
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Figure 8. (A) HPLC chromatogram of the standards: gallic acid (6.43 min), rutin (8.60 min), 
coumaric acid (9.43 min) and quercetin (11.13 min) and (B) F2 with the same retention 
times as the standard chemicals. 
 
 
3. Experimental 
3.1. Plant Extraction and Fractionation 
Dried leaves of P. minus were obtained from Ethno Resources Sdn Bhd, Selangor Malaysia, The 
plant was identified, and voucher specimen was kept in our laboratory for future references. Air-dried 
powdered leaves of P. minus were extracted by drenching in 95% ethanol (50 g/1000 mL, w/v) at 
room temperature for 3 days. Afterwards, the solvent was filtered, followed by concentration under 
reduced pressure until excess solvent was removed. The resulting yield was 5.8 g/100 g. Next, 1.5 g of 
the crude extract was chromatographed over silica gel (70–230 mesh, ASTM Merck KGaA) using 
FLEXTM columns. Different fractions were obtained from the stepwise elution of different ratios of 
hexane, ethyl acetate, methanol, acetonitrile, and distilled water. Depending on the TLC profile, 
similar fractions were combined. Ultimately, five fractions were obtained from P. minus leaf extract. 
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The first fraction, F1, was eluted with hexane:ethyl acetate 1:1 v/v to give 0.267 g. The second fraction, 
F2, was obtained using ethyl acetate:methanol 1:1 v/v and gave 0.651 g. The third fraction, F3, was 
eluted with methanol:acetonitrile 1:1 v/v and gave 0.241 g. The fourth fraction, F4, was eluted with 
acetonitrile:distilled water 1:1 v/v yielding 0.20 g1:1 v/v. Finally, the fifth fraction, F5, was eluted with 
distilled water producing 0.12 g1:1 v/v. The gastroprotective ability of all of the fractions was 
evaluated in order to identify the most active fraction. 
3.2. Experimental Protocol for Anti-Ulcer Evaluation 
Following the method described by Garg, et al. [33] with minor modifications, healthy male 
Sprague Dawley rats (150–200 g) were deprived of food for 48 h before the experiment was conducted, 
but were allowed free access to drinking water up until 2 h before the experiment. All rats were treated 
by orogastric intubations. The animals were divided randomly into seven groups of  
six rats per each. The first group, the negative control group, received carboxymethyl cellulose CMC, 
0.25% w/v, 5 mL/kg. The second group, which was the positive control group, received 20 mg/kg of 
omeprazole 5 mL/kg. The remaining groups, the treated groups, were pre-treated with 50 and 100 mg/kg 
of the fractions obtained from the ethanolic extract of P. minus: F1, F2, F3, F4, and F5, respectively. 
After one hour, all rats were administered 95% ethanol 5 mL/kg and after an additional 60 min, the rats 
were sacrificed by an overdose of ketamine 100 mg/mL. The stomach was rapidly removed for gross 
and histological evaluation and biochemical testing. 
3.3. Evaluation of Gross and Histological Changes 
Macroscopically, the lesions appeared as hemorrhage bands along the long axes of the stomach. 
The lesion of each stomach was calculated under a dissecting microscope (1.8×) using a 
hemocytometer (big square: length × width = 10 mm × 10 mm = ulcer area). The sum of the areas of 
all lesions for each stomach was implemented in the calculation of the ulcer area (UA) wherein the 
sum of small squares × 4 × 1.8 = UA (mm2) as described by Njar and Mahmood, et al. [34,35]. The 
ulcer inhibition percentage (I%) was calculated according to the following formula: 
[(I%) = [(UA control − UA treated) ÷ UA control] × 100%] 
Following the assessment of the ulcer score, stomachs were fixed in a buffered formalin (10%) 
solution for histological examination. The fixed stomachs were processed, sectioned every 5 μm and 
stained with H & E. 
3.4. Determination of Gastric Wall Mucus 
Gastric wall mucus was determined according to the procedure of Corne and Al-Qarawi, et al. [36,37]. 
The glandular portion of the stomach was removed, weighed and incubated in tubes containing 10 mL 
of 0.1% Alcian blue solution for 2 h, after which the excess dye was removed by two successive rinses 
with 10 mL of 0.25 M sucrose. Each stomach was extracted with 10 mL of 0.5 M magnesium chloride 
by intermittent shaking for 1 min at 30 min intervals for 2 h. The resultant solutions were vigorously 
shaken with an equal volume of diethyl ether and the emulsions were then centrifuged at 3000 g for  
10 min. The absorbency of the aqueous layer was measured against a buffer blank at 580 nm. The 
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quantity of blue dye recovered per gram of wet glandular tissue was then calculated from a  
standard curve. 
3.5. Preparation of Stomach Tissue Homogenate 
The stomachs were homogenized using ice cold Tris-HCl pH 8.2 (1 g in 10 mL) on ice. The 
homogenate tissues were centrifuged at 4500 g for 15 min at 4 °C, and then stored at −80 °C until they 
were used. In this study, the homogenate was analyzed in order to estimate superoxide dismutase, 
hexosamine and prostaglandin synthesis. 
3.5.1. Determination of Prostaglandin Synthesis 
Prostaglandin E2 (PGE2) levels produced in the gastric mucosa were measured following the 
procedure described in Cayman’s Protein Determination Kit. 
3.5.2. Determination of Total Hexosamine 
The concentration of hexosamine in stomach tissue was analysed according to the reported method 
of [38] with minor modifications. The hydrolyzation of stomach tissue was carried out using 6 M HCl, 
then neutralized using 6 M NaOH. Next, 0.5 mL of freshly prepared acetyl acetone was added to  
0.5 mL of the neutralized samples, and the mixture was boiled at 100 °C for 15 min. Following cooling 
of the mixture, 0.5 mL of Ehrlich reagent was added and the absorbance of colored chromogens was 
calculated at 530 nm using a UV 1601 spectrophotometer (Shimadzu-Japan). 
3.5.3. Determination of Superoxide Dismutase (SOD) 
Stomach superoxide dismutase activity was measured at 460 nm using a plate reader following the 
method reported in Cayman’s Superoxide Dismutase Assay Kit. 
3.6. Phytochemical Analysis 
3.6.1. HPLC 
Phytochemical analysis was conducted to identify phenolic compounds by using the high 
performance liquid chromatography (HPLC) method, using an LC-20AD apparatus (Shimadzu Corp, 
Kyoto, Japan) [39]. The experiments were carried out using a reversed phase C18 Hypersil GOLD 
column (250 mm × 4.6 mm; Thermo Fisher Scientific). The samples were eluted with a stepwise 
elution of the mobile phase as described in [40] with slight modifications. The mobile phase consisted 
of solvent A (H2O + 0.1% TFA) and solvent B (methanol + 0.1% TFA), at a unique flow rate of  
1 mL/min. The gradient elution program was as follows: 0 min 90% A:10% B; 5 min 55% A:45% B; 
20 min 50% A:50% B; 21 min 40% A:60% B; 22 min 90% A:10% B. The sample injection volume 
was 20 μL followed by equilibration run of 15 min and monitored with an SPD-20 A (UV) at 280 nm. 
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3.6.2. UPLC-ESI-MS/MS 
The phenolic profiles were further confirmed by ultra-performance liquid chromatography-electrospray 
tandem mass spectrometry. This method is described in detail by Chua, et al. [41]. To perform 
analytical UPLC, a Waters Acquity (Milford, MA, USA) system was coupled to a triple quadrupole-linear 
ion trap tandem mass spectrometer (Applied Biosystems 4000 Q TRAP; Life Technologies 
Corporation, Carlsbad, CA, USA) with an electrospray ionization (ESI) source. 
3.7. Statistical Analyses 
The data were analyzed using Statistical Package Social Science (SPSS), version 17.0 [42].  
One-way ANOVA was used to show the mean differences between all samples (* p < 0.05) using 
GraphPad PRISM®, version 5.0 [43]. 
4. Conclusions 
The ethyl acetate:methanol fraction 1:1 (F2) is the best fraction for gastroprotective activity against 
oxidative stress caused by ethanol induction model. The efficacy of F2 is based on its high content of 
phenolic compounds, particularly gallic acid and coumaric acid, which contribute to antioxidant 
activity, mucus barrier as well as maintenance of PGE2 and SOD levels (Scheme 1). This confirms the 
traditional use of P. minus for its gastroprotective capability and it can therefore be formulated and 
recommended to be a therapeutic drug for gastric ulcer. 
Scheme 1. The phenolic compounds in F2 prevent peptic ulcer generation by reactive 
oxygen species, particularly ethanol, by regulating mucous production, and maintaining 
PGE2, SOD and hexosamine levels. 
Increase pH, 
oxygen stress
& mucous damage
Scavenger enzyme 
dysfunction, Inhibition 
of mucus,PGE2&
hexoseamin
Phynolic
Compound  
from F2 
Oxidative 
Stress 
Prevention of 
mucous damage
by regulation of pH,
mucous barrier,
maintains of PGE2,
SOD & hexosamin
level
Ethanol
induction 
 
Int. J. Mol. Sci. 2012, 13 1493 
 
Acknowledgments 
The authors thank Research Manager Centre (RMC) UTM to provide the research fund grant via 
vote (QJ130000-7135-03J00) for financial support. 
References 
1. Klein, L.C.; Gandolfi, R.B.; Santin, J.R.; Lemos, M.; Filho, V.C.; de Andrade, S.F. 
Antiulcerogenic activity of extract, fractions, and some compounds obtained from  
Polygala cyparissias St. Hillaire & Moquin (Polygalaceae). Naunyn-Schmiedeberg’s Arch. 
Pharmacol. 2010, 381, 121–126. 
2. Bandyopadhyay, D.; Biswas, K.; Reiter, R.J.; Banerjee, R.K. Gastric toxicity and mucosal 
ulceration induced by oxygen-derived reactive species: protection by melatonin. Curr. Mol. Med. 
2001, 1, 501–513. 
3. Kaunitz, J.D.; Akiba, Y. Gastroduodenal mucosal defense: role of endogenous mediators.  
Curr. Opin. Gastroen. 2004, 20, 526–532. 
4. Tarnawski, A.S. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig. Dis. 
Sci. 2005, 50, 24–33. 
5. Burkill, I.H. A Dictionary of the Economic Products of the Malay Peninsula; Ministry of 
Agriculture: Kuala Lumpur, Malaysia, 1966; Volume 2, p. 1823. 
6. Faujan, N.H.; Abdullah, N.; Abdullah Sani, A.; Babji, A.M. Antioxidative activities of water 
extracts of some Malaysian herbs. ASEAN Food J. 2007, 14, 61–68. 
7. Qader, S.W.; Abdulla, M.A.; Chua, L.S.; Najim, N.; Zain, M.M.; Hamdan, S. Antioxidant, total 
phenolic content and cytotoxicity evaluation of selected Malaysian plants. Molecules 2011, 16, 
3433–3443. 
8. Gor, M.C.; Ismail, I.; Mustapha, W.A.W.; Zainal, Z.; Noor, N.M.; Othman, R.; Hussein, Z.A.M. 
Identification of cDNAs for jasmonic acid-responsive genes in Polygonum minus roots by 
suppression subtractive hybridization. Acta Physiol. Plant. 2011, 33, 283–294. 
9. Wasman, S.Q.; Mahmood, A.A.; Salehhuddin, H.; Zahra, A.A.; Salmah, I. Cytoprotective 
activities of Polygonum minus aqueous leaf extract on ethanol-induced gastric ulcer in rats.  
J. Med. Plants Res. 2010, 4, 2658–2665. 
10. Uyub, A.M.; Nwachukwu, I.N.; Azlan, A.A.; Fariza, S.S. In-vitro antibacterial activity and 
cytotoxicity of selected medicinal plant extracts from Penang Island Malaysia on  
metronidazole-resistant-Helicobacter pylori and some pathogenic bacteria. Ethnobot. Res. Appl. 
2010, 8, 95–106. 
11. Ali, A.M.; Mackeen, M.M.; El-Sharkawy, S.H.; Hamid, J.A.; Ismail, N.H.; Ahmad, F.;  
Lajis, M.N. Antiviral and cytotoxic activities of some plants used in Malaysian indigenous 
medicine. Pertanika J. Trop. Agric. Sci. 1996, 19, 129–136. 
12. Kinoshita, M.; Noto, T.; Tamaki, H. Effect of a combination of ecabet sodium and cimetidine on 
experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats. 
Biol. Pharm. Bull. 1995, 18, 223–226. 
Int. J. Mol. Sci. 2012, 13 1494 
 
13. Murata, H.; Kawano, S.; Tsuji, S.; Kamada, T.; Matsuzawa, Y.; Katsu, K.; Inoue, K.; Kobayashi, K.; 
Mitsufuji, S.; Bamba, T; et al. Combination therapy of ecabet sodium and cimetidine compared 
with cimetidine alone for gastric ulcer: Prospective randomized multicenter study. J. Gastroen. 
Hepatol. 2003, 18, 1029–1033. 
14. García-Barrantes, P.M.; Badilla, B. Anti-ulcerogenic properties of Quassia amara L.(Simaroubaceae) 
standardized extracts in rodent models. J. Ethnopharmacol. 2011, 134, 904–910. 
15. Alqasoumi, S.; Al-Sohaibani, M.; Al-Howiriny, T.; Al-Yahya, M.; Rafatullah, S. Rocket  
“Eruca sativa”: A salad herb with potential gastric anti-ulcer activity. World J. Gastroenterol. 
2009, 15, 1958–1965. 
16. German, M.; D’Angelo, V.; Biasini, T.; Miano, T.; Braca, A.; de Leo, M.; de Pasquale, R.; 
Sanogo, R. Anti-ulcer, anti-inflammatory and antioxidant activities of the n-butanol fraction from 
Pteleopsis suberosa stem bark. J. Ethnopharmacol. 2008, 115, 271–275. 
17. Gorinstein, S.; Vargas, O.J.M.; Jaramillo, N.O.; Salas, I.A.; Ayala, A.L.M.; Arancibia-Avila, P.; 
Toledo, F.; Katrich, E.; Trakhtenberg, S. The total polyphenols and the antioxidant potentials of 
some selected cereals and pseudocereals. Eur. Food Res. Technol. 2007, 225, 321–328. 
18. Scalzo, J.; Politi, A.; Pellegrini, N.; Mezzetti, B.; Battino, M. Plant genotype affects total 
antioxidant capacity and phenolic contents in fruit. Nutrition 2005, 21, 207–213. 
19. Miller, J.P.; Faragher, E.B. Relapse of duodenal ulcer: Does it matter which drug is used in initial 
treatment? Br. Med. J. 1986, 293, 1117–1118. 
20. Ariyphisi, I.; Toshiharu, A.; Sugimura, F.; Abe, M.; Matsuo, Y.; Honda, T. Recurrence during 
maintenance therapy with histamine H2 receptors antagonist in cases of gastric ulcers. Nikon Univ. 
J. Med. 1983, 28, 69–74. 
21. Reyes-Trejo, B.; Sánchez-Mendoza, M.E.; Becerra-García, A.A.; Cedillo-Portugal, E.;  
Castillo-Henkel, C.; Arrieta, J. Bioassay-guided isolation of an anti-ulcer diterpenoid from  
Croton reflexifolius: Role of nitric oxide, prostaglandins and sulfhydryls. J. Pharm. Pharmacol. 
2008, 60, 931–936. 
22. Nanjundaiah, S.M.; Annaiah, H.N.; Dharmesh S.M. Gastroprotective effect of ginger rhizome 
(Zingiber officinale) extract: Role of gallic acid and cinnamic acid in H+, K+-ATPase/H. pylori 
inhibition and anti-oxidative mechanism. Evid. Based Complement. Alternat. Med. 2011, 
doi:10.1093/ecam/nep060. 
23. Matsuda, H.; Pongpiriyadacha, Y.; Morikawa, T.; Ochi, M.; Yoshikawa, M. Gastroprotective 
effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats: structural requirements 
and mode of action. Eur. J. Pharmacol. 2003, 471, 59–67. 
24. de Sousa Falcão, H.; Leite, J.A.; Barbosa-Filho, J.M.; de Athayde-Filho, P.F.; de Oliveira Chaves, M.C.; 
Moura, M.D.; Ferreira, A.L.; de Almeida, A.B.A.; Souza-Brito, A.R.M.; de Fátima Formiga Melo Diniz, 
M.; et al. Gastric and duodenal antiulcer activity of alkaloids: A review. Molecules 2008, 13, 
3198–3223. 
25. Xia, J. Medicinal herbs used in pairs for treatment of 98 cases of chronic gastritis. J. Tradit. Chin. 
Med. 2004, 24, 208–209. 
26. Chakŭrski, I.; Matev, M.; Stefanov, G.; Koĭchev, A.; Angelova, I. Treanntment of duodenal ulcers 
and gastroduodenitis with a herbal combination of Symphitum officinalis and Calendula officinalis 
with and without antacids. Vutr. Boles. 1981, 20, 44–47. 
Int. J. Mol. Sci. 2012, 13 1495 
 
27. Chernomorets, N.N.; Seleznev, A.V.; Revutskiĭ, B.I.; Alifanova, R.E.; Kravchenko, Z.V.; 
Cherkasskaia, E.P. The differentiated phytotherapy of patients with duodenal peptic ulcer.  
Lik. Sprava 1992, 2, 112–115. 
28. Hiruma-Lima, C.A.; Calvo, T.R.; Rodrigues, C.M.; Andrade, F.D.P.; Vilegas, W.; Brito, A.R.M.S. 
Antiulcerogenic activity of Alchornea castaneaefolia: Effects on somatostatin, gastrin and 
prostaglandin. J. Ethnopharmacol. 2006, 104, 215–224. 
29. Banerjee, D.; Bauri, A.K.; Guha, R.K.; Bandyopadhyay, S.K.; Chattopadhyay, S. Healing 
properties of malabaricone B and malabaricone C, against indomethacin-induced gastric 
ulceration and mechanism of action. Eur. J. Pharmacol. 2008, 578, 300–312. 
30. Sánchez-Mendoza, M.E.; Reyes-Trejo, B.; Sánchez-Gómez, P.; Rodríguez-Silverio, J.;  
Castillo-Henkel, C.; Cervantes-Cuevas, H.; Arrieta, J. Bioassay-guided isolation of an anti-ulcer 
chromene from Eupatorium aschenbornianum: Role of nitric oxide, prostaglandins and sulfydryls. 
Fitoterapia 2010, 81, 66–71. 
31. Bhattacharya, S.; Chaudhuri, S.R.; Chattopadhyay, S.; Bandyopadhyay, S.K. Healing properties 
of some Indian medicinal plants against indomethacin-induced gastric ulceration of rats. J. Clin. 
Biochem. Nutr. 2007, 41, 106–114. 
32. Huda-Faujan, N.; Noriham, A.; Norrakiah, A.S.; Babji, A. Antioxidant activity of plants 
methanolic extracts containing phenolic compounds. Afr. J. Biotechnol. 2009, 8, 484–489. 
33. Garg, G.P.; Nigam, S.K.; Ogle, C.W. The gastric antiulcer effects of the leaves of the neem tree.  
Planta Med. 1993, 59, 215–217. 
34. Njar, V.C.O.; Adesanwo, J.K.; Raji, Y. Methyl angolenate: The antiulcer agent from the stem 
bark of Entandrophragma angolense. Planta Med. 1995, 61, 91–92. 
35. Mahmood, A.; Mariod, A.A.; Al-Bayaty, F.; Abdel-Wahab, S.I. Anti-ulcerogenic activity of 
Gynura procumbens leaf extract against experimentally-induced gastric lesions in rats. J. Med. 
Plant. Res. 2010, 4, 685–691. 
36. Corne, S.J.; Morrissey, S.M.; Woods, R.J. Proceedings: A method for the quantitative estimation 
of gastric barrier mucus. J. Physiol. 1974, 242, 116–117. 
37. Al-Qarawi, A.A.; Abdel-Rahman, H.; Ali, B.H.; Mousa, H.M.; El-Mougy, S.A. The ameliorative 
effect of dates (Phoenix dactylifera L.) on ethanol-induced gastric ulcer in rats. J. 
Ethnopharmacol. 2005, 98, 313–317. 
38. Jang, J.H.; Hia, H.C.; Ike, M.; Inoue, C.; Fujita, M.; Yoshida, T. Acid hydrolysis and quantitative 
determination of total hexosamines of an exopolysaccharide produced by Citrobacter sp. 
Biotechnol. Lett. 2005, 27, 13–18. 
39. Wang, H.; Helliwell, K. Determination of flavonols in green and black tea leaves and green tea 
infusions by high-performance liquid chromatography. Food Res. Int. 2001, 34, 223–227. 
40. Liza, M.S.; Rahman, R.A.; Mandana, B.; Jinap, S.; Rahmat, A.; Zaidul, I.S.M.; Hamid, A. 
Supercritical carbon dioxide extraction of bioactive flavonoid from Strobilanthes crispus  
(Pecah Kaca). Food Bioprod. Process. 2010, 88, 319–326. 
41. Chua, L.S.; Latiff, N.A.; Lee, S.Y.; Lee, C.T.; Sarmidi, M.R.; Aziz, R.A. Flavonoids and phenolic 
acids from Labisia pumila (Kacip Fatimah). Food Chem. 2011, 127, 1186–1192. 
42. Statistical Package Social Science, version 17.0; SAS Institute Inc.: Cary, NC, USA, 2009. 
Int. J. Mol. Sci. 2012, 13 1496 
 
43. GraphPad PRISM, version 5.0; Graph Pad Software, Inc.: San Diego, CA, USA, 2007. 
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
